A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235923 mixture of threonine, proline, glycine, valine, isoleucine, leucine, tyrosine, phenylalanine, lysine, aspartic acid, serine, glutamic acid, alanine, methionine, histidine and arginine as a unit; reduction of accumulated body fat, alleviation of excess sensitivity to cold, warming of a cold body
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235906 Substituted amine derivatives and their use as monoamine neurotransmitter re-up-take inhibitors
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235890 Remedies for allergic diseases
11/25/2004	US20040235889 administering imidazole, alanine, phenylalanine, substituted ethylamines, phenethylamine, histamine, histidine and linked di-imidazoles, that potentiate intraneuronal enzyme lyases; prophylaxis of neurodegenerative disorders
11/25/2004	US20040235887 Carbamates derived from arylalkylamines
11/25/2004	US20040235884 increasing choline transporters on the cell membrane of nervous systems by administering drugs such as 2-(2-oxopyrrolidin-1-yl)-N-(2,3dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4yl)acetamide; prophylaxis of nervous system disorders
11/25/2004	US20040235883 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
11/25/2004	US20040235880 2-(9-Chloro-3-methyl-4oxo-5H-isoxazolo[4,3-c]quinolin-5-yl)-pyridine, optionally substituted in the 6 positionof the pyridine ring; coadministering with vincristine, epirubicin, daunorubucin, doxorubicin, or etoposide to reduce the severity of MRP1 derived drug resistance
11/25/2004	US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004	US20040235871 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235822 Benzazepine derivative, process for producing the same, and use
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235809 Epoxy steroidal aldosterone antagonist and beta-adremergic antagonist combination therepy for treatment of congestive heart failure
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235802 Combinations comprising cox-2-inhibitors and aspirin
11/25/2004	US20040235799 Use of a compound with a negatively charged domain of radicals for the treatment of restenosis
11/25/2004	US20040235796 For therapy of proliferative disease
11/25/2004	US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235785 Potentiator of antitumoral agents in the treatment of cancer
11/25/2004	US20040235783 Pharmaceutical compositions for the treatment of tumor diseases
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040235755 Modulating glycolysis enzyme complex/M2-PK and/or by inhibiting transaminases and/or separating the binding of the mitochondrial malate dehydrogenase to p36 protein
11/25/2004	US20040235754 Dipeptide derivatives
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040235748 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/25/2004	US20040235731 package contains low molecular weight peptide-based thrombin inhibitors (melagatran), sealed with rubber stopper/plunger
11/25/2004	US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004	US20040235718 Use of Afamin, in particular in combination with vitamin E, is for treatment of oxidative stress; treatment of Alzheimer's Disease, Huntington's Disease or amyotropic lateral sclerosis
11/25/2004	US20040235163 Comprises regulatory agent which prevents apoptosis and/or cardiac oxidative stress in myocardial tissues; identifying modulators of atp sensitive potassium channels
11/25/2004	US20040235159 Using nutrient broth comprising cell proliferative agents and mouse embryonic fibroblasts to propagating pluripotent stem cells for use in cell replacement therapies
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235044 Chain-shortened polynucleotide and method for preparation thereof
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234985 Method
11/25/2004	US20040234969 Using cytochrome p450 gene expression as diagnostic indicator of steroid responsiveness; identifying modulators for treatment and prevention of skin and allergic disorders
11/25/2004	US20040234674 Artichoke leaf extracts
11/25/2004	US20040234632 Use of oil from seeds of gourd family members chosen from Lagenaria, Luffa, and Momordica for preparing composition to inhibit 5a-reductase activity; for treatment of prostatic hypertrophy, prostatic adenoma, acne, hyperseborrhea, alopecia and hirsutism
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234555 Using 5-aminolevulinic acid
11/25/2004	US20040234544 Formulation containing (lyso-)phosphatidylserine for the prevention and treatment of stress states in warm blooded animals
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234523 Antiischemic agents; synergistic mixture of interleukin inhibitor and tumor necrosis factor antagonist
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234502 Method for treatment of vascular regeneration
11/25/2004	US20040234495 Antitumor agents and process for producing the same
11/25/2004	US20040234472 Micellar drug delivery systems for hydrophobic drugs
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2523978A1 Crystal of benzimidazole derivative and process for producing the same
11/24/2004	EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1479384A1 Fibrosis inhibitor
11/24/2004	EP1478927A2 Macromolecular conjugates and processes for preparing same
11/24/2004	EP1478784A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
11/24/2004	EP1478778A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
11/24/2004	EP1478770A2 Screening method for orthopoxvirus antivirals
11/24/2004	EP1478766A2 Methods for determining the influence of protein binding on antiretroviral activity
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478735A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/24/2004	EP1478660A2 KAPPA−PVIIA−RELATED CONOTOXINS AS ORGAN PROTECTANTS
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004	EP1478646A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
11/24/2004	EP1478635A1 Process for the production of citalopram

1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1564